STE
Medical Devices · Healthcare
CFO
Equibles does not estimate personal net worth.
Earlier roles on record: CFO at STERIS plc (STE) until July 31, 2025. STERIS plc reported in an 8-K filed August 6, 2025 that Michael Tokich resigned as Senior Vice President and Chief Financial Officer, effective July 31, 2025. The proxy statement of STERIS plc reports total compensation of $2,229,993 for Michael Tokich in fiscal 2026, including a base salary of $511,409. Disclosed compensation is on record for 9 fiscal years. Michael Tokich has spoken on 9 earnings calls across 1 company, most recently for STERIS plc on August 6, 2025. The companies whose calls Michael Tokich spoke on are classified in the Healthcare sector.
“On July 31, 2025, Michael J. Tokich notified the Board of Directors (the "Board") of his resignation from his current role as Senior Vice President and Chief Financial Officer of the Company.”
“It is once again my pleasure to be with you this morning to review the highlights of our first quarter performance from continuing operations. For the first quarter, total as reported revenue grew 9%.”
“It is once again my pleasure to be with you this morning to review the highlights of our first quarter performance. For the quarter, constant currency organic revenue increased 11%, driven by volume as well as 290 basis points of price.”
“It is once again my pleasure to be with you this morning to review the highlights of our fourth quarter performance. Following my review, Dan will comment on the full year of fiscal '23 and talk about our outlook for fiscal '24.”
“It is once again my pleasure to be with you this morning to review the highlights of our third quarter performance. For the quarter, constant currency organic revenue increased 7%, driven by volume as well as 300 basis points of price.”
“It is once again my pleasure to be with you this morning to review the highlights of our second quarter performance. For the quarter, constant currency organic revenue increased 7%, driven by volume as well as 290 basis points of price.”
Start not stated–2025-07-31
STE
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | STERIS plc (STE) | Senior Financial Advisor | $511,409 | $2,229,993 |
| 2025 | STERIS plc (STE) | Senior Vice President and Chief Financial Officer | $633,463 | $3,312,737 |
| 2024 | STERIS plc (STE) | Senior Vice President and Chief Financial Officer | $613,770 | $3,243,894 |
| 2023 | STERIS plc (STE) | Senior Vice President and Chief Financial Officer | $590,356 | $2,890,072 |
| 2022 | STERIS plc (STE) | Senior Vice President and Chief Financial Officer | $555,800 | $3,259,796 |
| 2021 | STERIS plc (STE) | Senior Vice President and Chief Financial Officer | $536,125 | $2,857,857 |
| 2020 | STERIS plc (STE) | Senior Vice President and Chief Financial Officer | $515,750 | $2,567,972 |
| 2019 | STERIS plc (STE) | Senior Vice President and Chief Financial Officer | $484,750 | $2,246,891 |
| 2018 | STERIS plc (STE) | Senior Vice President and Chief Financial Officer | $472,308 | $1,795,295 |